Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
J Colloid Interface Sci ; 562: 453-460, 2020 Mar 07.
Article in English | MEDLINE | ID: mdl-31874714

ABSTRACT

Semiconducting 2D siloxene nanosheets of thickness 1.7 nm and band gap of 2.54 eV are synthesized using simple chemical route. Strong photoluminescence is observed in the as-synthesized nanosheets due to presence of oxygen atoms. The photoluminescence behaviour of siloxene nanosheets is investigated by controlling temperature, excitation and pH of the solution to understand the optical response and stability of the material. The as-synthesized sample heated with temperature 200 °C shows a blue shift of 90 nm compared to the sample synthesized at room temperature. The low temperature luminescence measurements of as-synthesized samples dried at different temperatures viz. 27, 100 and 200 °C. It is seen that the luminescence intensity is increasing with decreasing temperature for the sample dried at room temperature. However, after heating the sample at 100 °C, the luminescence intensity is not only increased but also red-shifted up to 52 nm. The photocurrent has been measured for the device structure of ITO/PEDOT: PSS/Siloxene/Al with different film thicknesses to optimize the photocurrent and the maximum percentage change in photo power gain. The maximum photopower gain of 2693% is observed for the film thickness of 600 nm.

2.
J Colloid Interface Sci ; 553: 177-185, 2019 Oct 01.
Article in English | MEDLINE | ID: mdl-31202054

ABSTRACT

Although, great attention is paid to synthesize fluorescent carbon quantum dots (CQDs) for versatile applications, the field remains still attractive to achieve white light using these nano materials. In the present work, CQDs are synthesized from citric acid and lanthanide ions viz. Europium (Eu) and Terbium (Tb) are doped in CQD moiety to explore superior optical response for multifunctional applications. By proper tuning of excitation wavelength, perfect white light with Commission Internationale de l'Elcairage (CIE) index (0.345, 0.344) is obtained using these Europium Terbium co-doped CQDs (Eu-Tb-CQD). The observed photoluminescence of white light emitting lanthanide based CQD is pH dependent and will be used as a visual pH sensor. These luminescent Eu and Tb co-doped CQDs are also very useful to detect toxic Cr (VI) with excellent selectivity and sensitivity as compared to pure CQDs. It shows high quenching efficiency (∼95%) in presence of only 160 µM Cr(VI). The selectivity and lower detection limit are also obtained as ∼80% and 0.175 µM respectively.

3.
ACS Omega ; 3(9): 11439-11446, 2018 Sep 30.
Article in English | MEDLINE | ID: mdl-31459247

ABSTRACT

We report very fast, green, and large-scale synthesis of amino-functionalized carbon quantum dots (CQDs) using a domestic microwave to investigate CQD-Tb-based dual emission for visual detection of toxic Hg2+. Citric acid and p-phenylenediamine are used as precursor materials to synthesize the CQD, which shows excitation-independent blue luminescence. To achieve the dual emission, Tb-containing CQD is synthesized in a very easy and cost-effective way. These dual-emissive fluorescent materials have been successfully used as a fluorescent indicator for visual detection of toxic Hg2+ metal ions. An instant color change from blue to green in the presence of a very low amount of Hg2+ under a UV lamp (λ365nm) is observed. The material is highly sensitive and selective toward detection of mercury ions in the presence of other metal ions. The photoluminescence quenching mechanism (photoinduced electron transfer process) has been explained using an electronic band diagram supported by zeta-potential and time-correlated single photon counting measurements.

4.
Clin Appl Thromb Hemost ; 24(3): 405-415, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29277101

ABSTRACT

The objective of this literature review was to estimate the incidence of thrombosis and thromboembolism associated with the superior cavopulmonary anastomosis (SCPA) procedure and its variants and to examine current thromboprophylaxis regimens utilized. MEDLINE and EMBASE were searched from inception to August 2017 for all prospective and retrospective cohort studies explicitly reporting incidence of thrombosis, thromboembolism, or shunt occlusion in neonates, infants, and children undergoing 1 or more variants of the SCPA procedure. End points included thrombotic events and thromboembolic events (strokes and pulmonary embolisms) as primary outcomes, and overall mortality as a secondary outcome, at the last available follow-up time point. Of 1303 unique references identified, 13 cohort studies were deemed eligible. Reported incidence of thrombosis and thromboembolic events ranged from 0% to 28.0% and from 0% to 12.5%, respectively. Reported incidence of major bleeding events ranged from 0% to 2.9%. Reported overall mortality ranged from 2.5% to 50.5% across studies. Thromboprophylaxis protocols varied across institutions and studies, most commonly involving unfractionated heparin (UFH), warfarin, enoxaparin, acetylsalicylic acid (ASA), or combinations of ASA and warfarin, ASA and low-molecular-weight heparin (LMWH), UFH and LMWH, and UFH and ASA; several studies did not specify a protocol. Due to substantial variability in reported event rates, no clear correlation was identified between prophylaxis protocols and postoperative thrombotic complications. Despite guidance recommending postoperative UFH as standard practice, thromboprophylaxis protocols varied across institutions and studies. More robust trials evaluating different thromboprophylaxis regimens for the management of these patients are warranted.


Subject(s)
Heart Bypass, Right/adverse effects , Disease Management , Humans , Incidence , Thromboembolism/etiology , Thromboembolism/prevention & control , Thrombosis/etiology , Thrombosis/prevention & control
5.
Article in English | MEDLINE | ID: mdl-22446758

ABSTRACT

Spectroscopic studies of Naproxen (NP), a nonsteroidal drug have been carried out in well characterized, micellar media of cationic surfactants of a homologous series having general formula C(n)TAB (alkyl trimethyl ammonium bromide) and of nonionic surfactants of Igepal (Ig) series (poly(oxyethylene) nonyl phenol). The fluorescence behavior of the drug molecule in C(n)TAB micelles has been found to be opposite to that in Igepal micelles. The binding constants during probe micelle binding have been evaluated from relevant fluorescence data. Location and nature of the surrounding medium of the probe in micellar media have been ascertained from fluorescence quenching study. Fluorescence anisotropy parameter has been monitored for exploring the imposed motional restriction of the microenvironment around the probe. Contrasting behavior of the drug molecule has been observed in two different types of micelles. Based on the experimental and theoretical studies, an attempt has been made to explain the different behavior of the probe in different media.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/chemistry , Micelles , Naproxen/chemistry , Phenols/chemistry , Polyethylene Glycols/chemistry , Fluorescence Polarization , Surface-Active Agents/chemistry
6.
Paediatr Child Health ; 16(4): e30-2, 2011 Apr.
Article in English | MEDLINE | ID: mdl-22468132

ABSTRACT

Captopril, an angiotensin-converting enzyme inhibitor used to manage congestive heart failure in the paediatric population, has limited data on efficacy and safety. Its variety of liquid formulations dispensed by different pharmacies poses a challenge in optimizing captopril dosing in patients. Fourteen tertiary paediatric centre pharmacies across Canada were contacted to decipher the type of captopril formulation they dispense, their recipe and the stability of each formulation. Of the 14 centres surveyed, four dispensed solid tablets, two dispensed either solid tablets or liquid formulations, and eight dispensed extemporaneously prepared liquid formulations. There was also great variety in the solutions used to prepare the liquid formulations. The bioequivalence of these preparations has not been studied. As a result, physicians cannot be certain about the effective dose of captopril. Uniformity is recommended among paediatric pharmacies in Canada when preparing medications such as captopril. Proper testing of the stability and bioequivalence of medications is recommended.

SELECTION OF CITATIONS
SEARCH DETAIL
...